SBIR PHASE I ANTIBODY ARRAY FOR CANCER DETECTION (TOPIC236)

Award Information

Agency: Department of Health and Human Services	Branch: N/A	Award ID: 94137	Program Year/Program: 2008 / SBIR
Agency Tracking Number: N43CN0800020	Solicitation Year: N/A	Solicitation Topic Code: N/A	Solicitation Number: N/A

Small Business Information: PHARMASEQ, INC.
PHARMASEQ, INC. 11 DEER PARK DR, STE 104 MONMOUTH JUNCTION, NJ 99999-
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 1: Fiscal Year: 2008

Title: SBIR PHASE I ANTIBODY ARRAY FOR CANCER DETECTION (TOPIC236)

Agency: HHS

Contract: N43CN0800020

Award Amount: $150,000.00

Abstract:
This Phase I project aims to develop a technology to simultaneously measure three biomarkders for early prostate cancer detection using an electronic radio frequency (RF) light-powered microtransponder. Antigens will be captured using antibodies coupled to the microtransponders and detected using biotinylated antibodies.

Principal Investigator:
Wlodek Mandecki
7323550100
mandecki@pharmaseq.com

Business Contact:

mandecki@pharmaseq.com

Small Business Information at Submission:

PHARMASEQ, INC.
PHARMASEQ, INC. 11 DEER PARK DR, STE 104 MONMOUTH JUNCTION, NJ 08852

EIN/Tax ID:

DUNS: N/A

Number of Employees: N/A

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No